Thu, Jul 24, 2014, 6:49 AM EDT - U.S. Markets open in 2 hrs 41 mins


% | $
Click the to save as a favorite.

Abbott Laboratories Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • jak.stat jak.stat Jun 12, 2011 11:37 PM Flag

    AMA's new CEO. Unbelievable.

    What's wrong with a scientist/pathologist leading AMA?

    What's your problem??

    Why do you post here???

    Why should a "practicing physician" be more qualified to lead AMA????

    Are you insane????

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Gotta weigh-in on this.
      Only about 20% of practicing physicians in the US are members of the AMA (DHHS-AMA figures)
      "clinicians" have always resented pathologists since they have the real understanding of disease processes and have been the "truth cops" that sometimes trip-up clinicians who are esteemed by patients for their "laying-on of hands". This visibility imparts an aura of infallibility that clinicians buy into.
      In fact many diagnoses are made in the lab, NOT by pathologists (research, clinical, "basic scientist", diagnostic pathologist, or whatever semantics one wants to apply). They are made by non-physicians and even non-PhDs but by Registered Medical (Laboratory) Technologists/Medical Laboratory Scientists (alternate certification), microbiologists, toxicologists, etc. Furthermore assessment of the efficacy of most patient treatments would not be possible without lab often headed by clinical pathologists. Most pathologists (clinical or therwise) are totally unprepared to function in a clinical laboratory or blood bank.
      None-the-less the contribution of pathologists to patient care and outcomes warrants their appointment as CEO of AMA.

    • The AMA should not be led by a basic scientist with contempt for clinicians.

42.97-0.12(-0.28%)Jul 23 4:01 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Facebook, Inc.
NasdaqGSWed, Jul 23, 2014 4:00 PM EDT
Xilinx Inc.
NasdaqGSWed, Jul 23, 2014 4:00 PM EDT